Diabetic Wounds Market Report 2026

The diabetic wounds market size has grown strongly in recent years. It will grow from $2.33 billion in 2025 to $2.49 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to high incidence of chronic diabetic wounds, delayed healing outcomes, limited access to advanced wound care, hospital-centered treatment models, rising amputation risk.

The diabetic wounds market size is expected to see strong growth in the next few years. It will grow to $3.26 billion in 2030 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to growth in regenerative medicine, expansion of homecare services, innovation in wound dressings, increasing outpatient care adoption, focus on reducing complications. Major trends in the forecast period include increasing use of advanced wound care products, growing adoption of biologic and regenerative therapies, rising demand for home-based wound management, expansion of chronic wound care centers, increased focus on infection prevention.

The rising incidence of obesity is expected to drive the growth of the diabetic wounds market in the coming years. Obesity is a health condition characterized by excessive accumulation of body fat that can negatively affect overall health. The increasing prevalence of obesity is largely attributed to more sedentary lifestyles, with individuals spending extended periods inactive and engaging in limited physical activity. Obesity is closely associated with diabetic wounds, as excess body fat can contribute to insulin resistance, impair blood glucose control, and slow wound healing. For instance, in September 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, 23 states reported adult obesity prevalence rates of 35% or higher in 2023, while all 50 states recorded obesity rates of at least 20%. Therefore, the growing prevalence of obesity is driving the expansion of the diabetic wounds market.

Major companies operating in the diabetic wounds market are concentrating on the development of advanced solutions, such as portable negative pressure wound therapy (NPWT) systems, to enable more effective, convenient, and patient-focused management of diabetic foot ulcers and other chronic wounds. Portable NPWT systems use controlled suction delivered through a compact pump and sealed dressing to remove wound exudate, reduce edema, improve blood circulation, and accelerate tissue regeneration, offering an active therapeutic alternative to conventional wound dressings. For instance, in April 2024, Smith+Nephew, a UK-based medical technology company, launched the RENASYS EDGE NPWT System, a next-generation device designed for home use with an emphasis on simplicity and comfort. The system features a lightweight and quiet design, a discreet 300 mL canister, guided setup animations through an intuitive interface, more than 24 hours of battery life, and built-in self-test functionality to reduce maintenance requirements. These features make the device easier for patients to wear and operate, allowing wound therapy to be seamlessly integrated into daily routines.

In May 2023, LifeNet Health, a US-based regenerative medicine solutions provider, acquired the wound care division of Bioventus Inc. for $85 million. Through this acquisition, LifeNet Health aims to strengthen its wound care portfolio by incorporating Bioventus’ TheraSkin product and enhance its position as a global leader in regenerative medicine. Bioventus Inc. is a US-based biotechnology company specializing in advanced wound care products, including TheraSkin, which supports improved healing outcomes in diabetic foot ulcers.

Major companies operating in the diabetic wounds market are 3M Health Care, Medline Industries Inc., B. Braun Melsungen AG, Smith & Nephew plc, Coloplast A/S, Hartmann Group, ConvaTec Group Plc, Mölnlycke Health Care AB, Integra LifeSciences Holdings Corporation, Hollister Incorporated, Organogenesis Inc., MiMedx Group Inc., LifeNet Health, Derma Sciences Inc., Kerecis, DermaRite Industries LLC, MediWound Ltd., Tissue Regenix Group plc, Systagenix Wound Management, XenoTherapeutics, Alliqua BioMedical Inc.

North America was the largest region in the diabetic wounds market in 2025. The regions covered in the diabetic wounds market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the diabetic wounds market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the diabetic wounds market by increasing costs of imported wound dressings, biologic materials, and wound therapy devices. Hospitals and wound care clinics in developed regions are most affected due to reliance on imported advanced products, while emerging markets face affordability constraints. These tariffs increase treatment costs. However, they encourage domestic production of wound care consumables and localized supply chains.

The diabetic wounds market research report is one of a series of new reports that provides diabetic wounds market statistics, including diabetic wounds industry global market size, regional shares, competitors with a diabetic wounds market share, detailed diabetic wounds market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic wounds industry. This diabetic wounds market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Diabetic wounds are wounds that heal slowly and commonly develop in individuals with diabetes. They arise due to a combination of factors such as neuropathy, impaired circulation, and elevated blood glucose levels, which disrupt normal healing processes and increase the risk of infection and related complications.

The product types used for diabetic wound management include wound care dressings, wound care devices, skin grafts and substitutes, growth factors, and others. Wound care dressings are specialized materials applied directly to diabetic wounds to protect them from contamination and support the healing process. The different wound types include neuropathic ulcer wounds, ischemic ulcer wounds, and neuro-ischemic ulcer wounds, and these products are used by end users such as hospitals, specialty clinics, and others.

The diabetic wounds market consists of sales of antibacterial creams, gels, negative pressure wound therapy (NPWT) systems, and wound cleansers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.